The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo

BACKGROUND: Novel synthesized analogs of Aplidin, PM01215 and PM02781, were tested for antiangiogenic effects on primary human endothelial cells in vitro and for inhibition of angiogenesis and tumor growth in vivo. METHODS: Antiangiogenic activity of both derivatives was evaluated by real-time cell...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Borjan, Bojana, Steiner, Normann, Karbon, Silvia, Kern, Johann, Francesch, Andrés, Hermann, Martin, Willenbacher, Wolfgang, Gunsilius, Eberhard, Untergasser, Gerold
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615365/
https://ncbi.nlm.nih.gov/pubmed/26483043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1729-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia